Accessibility Menu
BioArctic Ab (publ) logo

BioArctic Ab (publ)

(OTC) BRCTF

Current Price$35.00
Market Cap$3.11B
Since IPO (2022)+33%
5 YearN/A
1 Year+82%
1 Month+2%

BioArctic Ab (publ) Financials at a Glance

Market Cap

$3.11B

Revenue (TTM)

SEK 1.15B

Net Income (TTM)

SEK 213.27M

EPS (TTM)

$0.26

P/E Ratio

133.95

Dividend

$0.21

Beta (Volatility)

0.00 (Low)

Price

$35.00

Volume

5

Open

$35.00

Previous Close

$35.00

Daily Range

$35.00 - $35.00

52-Week Range

$19.34 - $40.00

Estimated Earnings Date

Aug 26, 2026

BRCTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioArctic Ab (publ)

Industry

Biotechnology

Employees

141

CEO

Gunilla Christina Osswald, PhD

Headquarters

Stockholm, BC 112 51, SE

BRCTF Financials

Key Financial Metrics (TTM)

Gross Margin

94.13%

Operating Margin

34.50%

Net Income Margin

18.59%

Return on Equity

10.44%

Return on Capital

68.02%

Return on Assets

7.96%

Earnings Yield

0.75%

Dividend Yield

0.61%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.11B

Shares Outstanding

88.72M

Volume

5

Avg. Volume

18.095

Financials (TTM)

Gross Profit

SEK 1.08B

Operating Income

SEK 395.70M

EBITDA

SEK 431.66M

Operating Cash Flow

SEK 1.25B

Capital Expenditure

-SEK 433.22M

Free Cash Flow

SEK 1.25B

Cash & ST Invst.

SEK 2.03B

Total Debt

SEK 40.74M

BioArctic Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 437.59M

-66.1%

Gross Profit

SEK 418.04M

-67.3%

Gross Margin

95.53%

N/A

Market Cap

$3.11B

N/A

Market Cap/Employee

$23.71M

N/A

Employees

131

N/A

Net Income

SEK 212.39M

-79.2%

EBITDA

SEK 224.65M

-79.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 2.03B

+158.0%

Total Debt

SEK 40.74M

-20.1%

Accounts Receivable

SEK 0.00

N/A

Inventory

SEK 0.00

N/A

Long Term Debt

SEK 25.04M

-33.5%

Short Term Debt

SEK 31.33M

+135.4%

Return on Assets

7.96%

N/A

Return on Invested Capital

17.34%

N/A

Free Cash Flow

-SEK 166.00M

-1508.1%

Operating Cash Flow

-SEK 166.00M

-1508.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GENSFGenus plc
$31.07+0.00%
HTSUFHisamitsu Pharmaceutical Co., Inc.
$29.00+0.00%
MEOBFMesoblast Limited
$1.55+0.00%
ONTTFOxford Nanopore Technologies plc
$1.70+3.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$18.15+0.00%
SPCXSpace Exploration Technologies
$157.54-0.08%
ONDSOndas
$7.92-0.04%
PATHUiPath
$11.55+0.06%

Questions About BRCTF

What is the current price of BioArctic Ab (publ)?

BioArctic Ab (publ) is trading at $35.00 per share.

What is the 52-week range for BioArctic Ab (publ)?

Over the past 52 weeks, BioArctic Ab (publ) has traded between $19.34 and $40.00.

How much debt does BioArctic Ab (publ) have?

As of the most recent reporting period, BioArctic Ab (publ) reported total debt of SEK 4.28M.

How much cash does BioArctic Ab (publ) have on hand?

BioArctic Ab (publ) reported SEK 126.46M in cash and cash equivalents in its most recent financial results.

What is BioArctic Ab (publ)’s dividend yield?

BioArctic Ab (publ) currently has a dividend yield of 0.61%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.